{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:51:35Z","timestamp":1762113095909,"version":"3.37.3"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1124\/mol.108.046540","type":"journal-article","created":{"date-parts":[[2008,2,27]],"date-time":"2008-02-27T02:21:00Z","timestamp":1204078860000},"page":"1339-1342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Messing Up with Traffic: Different Effects of Antipsychotic Agents on Glutamate Receptor Complexes in Vivo"],"prefix":"10.1016","volume":"73","author":[{"given":"Thomas","family":"Del\u2019guidice","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Martin","family":"Beaulieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.108.046540_REF1","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1523\/JNEUROSCI.3116-05.2006","article-title":"Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B","volume":"26","author":"Bayer","year":"2006","journal-title":"J Neurosci"},{"key":"10.1124\/mol.108.046540_REF2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tips.2007.02.006","article-title":"The Akt-GSK-3 signaling cascade in the actions of dopamine","volume":"28","author":"Beaulieu","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.108.046540_REF3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2007.11.041","article-title":"A beta-arrestin 2 signaling complex mediates lithium action on behavior","volume":"132","author":"Beaulieu","year":"2008","journal-title":"Cell"},{"key":"10.1124\/mol.108.046540_REF4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","article-title":"An Akt\/beta-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior","volume":"122","author":"Beaulieu","year":"2005","journal-title":"Cell"},{"key":"10.1124\/mol.108.046540_REF5","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.108.046540_REF6","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1126\/science.287.5460.2020","article-title":"Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation","volume":"287","author":"Castner","year":"2000","journal-title":"Science"},{"key":"10.1124\/mol.108.046540_REF7","doi-asserted-by":"crossref","first-page":"pe20","DOI":"10.1126\/stke.3332006pe20","article-title":"Where do you think you are going? The NMDA-D1 receptor trap","volume":"2006","author":"Cepeda","year":"2006","journal-title":"Sci STKE"},{"key":"10.1124\/mol.108.046540_REF8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"Creese","year":"1976","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1124\/mol.108.046540_REF9","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1055\/s-2007-992133","article-title":"Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action","volume":"40","author":"Di Pietro","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"10.1124\/mol.108.046540_REF10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nn997","article-title":"PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity","volume":"6","author":"Esteban","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1124\/mol.108.046540_REF11","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1124\/mol.107.043786","article-title":"Dynamic regulation of glutamatergic postsynaptic activity in rat prefrontal cortex by repeated administration of antipsychotic drugs","volume":"73","author":"Fumagalli","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.108.046540_REF12","doi-asserted-by":"crossref","unstructured":"Gardoni F, Frasca A, Zianni E, Riva MA, Di Luca M, and Fumagalli F (2008) Repeated treatment with haloperidol, but not olanzapine, alters synaptic NMDA receptor composition in rat striatum. Eur Neuropsychopharmacol, in press.","DOI":"10.1016\/j.euroneuro.2007.10.004"},{"key":"10.1124\/mol.108.046540_REF13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0962-8924(96)10036-2","article-title":"Synaptic proteins and the assembly of synaptic junctions","volume":"6","author":"Garner","year":"1996","journal-title":"Trends Cell Biol"},{"key":"10.1124\/mol.108.046540_REF14","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.4088\/JCP.1007e24","article-title":"Metabolic risks and effects of atypical antipsychotic treatment","volume":"68","author":"Haupt","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/mol.108.046540_REF15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1146\/annurev.biochem.71.110601.135410","article-title":"Neuronal Ca2+\/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function","volume":"71","author":"Hudmon","year":"2002","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/mol.108.046540_REF16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(75)90206-8","article-title":"Letter: Clozapine and agranulocytosis","volume":"2","author":"Id\u00e4np\u00e4\u00e4n-Heikkil\u00e4","year":"1975","journal-title":"Lancet"},{"key":"10.1124\/mol.108.046540_REF17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.med.52.1.503","article-title":"Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia","volume":"52","author":"Kapur","year":"2001","journal-title":"Annu Rev Med"},{"key":"10.1124\/mol.108.046540_REF18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biopsych.2005.06.022","article-title":"Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis","volume":"59","author":"Keefe","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1124\/mol.108.046540_REF19","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.108.046540_REF20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/schbul\/17.2.263","article-title":"The mechanism of action of novel antipsychotic drugs","volume":"17","author":"Meltzer","year":"1991","journal-title":"Schizophr Bull"},{"key":"10.1124\/mol.108.046540_REF21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol Rev"},{"key":"10.1124\/mol.108.046540_REF22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0092-8674(00)81972-8","article-title":"Mice with reduced NMDA receptor expression display behaviors related to schizophrenia","volume":"98","author":"Mohn","year":"1999","journal-title":"Cell"},{"key":"10.1124\/mol.108.046540_REF23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1017\/S1461145704004262","article-title":"A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis","volume":"7","author":"Oosthuizen","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/mol.108.046540_REF24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2007.01.029","article-title":"LTP inhibits LTD in the hippocampus via regulation of GSK3beta","volume":"53","author":"Peineau","year":"2007","journal-title":"Neuron"},{"key":"10.1124\/mol.108.046540_REF25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd1346","article-title":"Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia","volume":"3","author":"Roth","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/mol.108.046540_REF26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0166-2236(00)01817-8","article-title":"Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?","volume":"24","author":"Sharp","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1124\/mol.108.046540_REF27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1146\/annurev.biochem.76.060805.160029","article-title":"The postsynaptic architecture of excitatory synapses: a more quantitative view","volume":"76","author":"Sheng","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/mol.108.046540_REF28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0896-6273(04)00048-0","article-title":"Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity","volume":"41","author":"Yao","year":"2004","journal-title":"Neuron"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24048375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24048375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.108.046540","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:56:50Z","timestamp":1739959010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24048375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0026895X24048375"],"URL":"https:\/\/doi.org\/10.1124\/mol.108.046540","relation":{},"ISSN":["0026-895X"],"issn-type":[{"type":"print","value":"0026-895X"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Messing Up with Traffic: Different Effects of Antipsychotic Agents on Glutamate Receptor Complexes in Vivo","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.108.046540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}